特发性快速眼动睡眠行为障碍病理的在体分期:多模态影像病例对照研究
这项前瞻性病例对照研究纳入22例经多导睡眠图确诊的特发性快速眼动睡眠行为障碍患者,采用多模态影像评估自主神经、去甲肾上腺素能与多巴胺能神经支配,发现患者周围自主神经系统与蓝斑病理已充分发展、与帕金森病相当,但多数患者壳核多巴胺储存能力正常,支持α-突触核蛋白病理由周围自主神经向头侧脑干播散的假说。
要点
- 特发性快速眼动睡眠行为障碍患者结肠胆碱能、心脏交感、蓝斑色素神经元及壳核多巴胺摄取均低于对照。
- 上述周围自主神经与蓝斑指标与帕金森病患者无组间差异。
- 21例患者中15例(71%)壳核18F-DOPA Ki值在正常范围内。
核心结论
- 特发性快速眼动睡眠行为障碍患者周围自主神经系统与蓝斑病理已充分发展,程度与确诊帕金森病相当。
- 患者同时存在丘脑去甲肾上腺素能神经支配缺失,但多数壳核多巴胺储存能力正常。
- 这种由尾侧向头侧的功能障碍梯度支持α-突触核蛋白病理先累及周围自主神经、再向头侧播散至脑干的假说。
研究设计与样本
- 前瞻性病例对照研究,2016年6月3日至2017年12月19日经广告及丹麦睡眠门诊招募22例经多导睡眠图确诊、无帕金森综合征或痴呆临床征象的特发性快速眼动睡眠行为障碍患者。
- 采用11C-多奈哌齐PET与CT评估结肠胆碱能(副交感)神经支配。
- 采用123I-间碘苄胍(MIBG)闪烁显像测量心脏交感神经支配。
- 采用黑素敏感MRI测量蓝斑色素神经元完整性,11C-甲基瑞波西汀(MeNER)PET评估起源于蓝斑的去甲肾上腺素能神经末梢,18F-二羟基苯丙氨酸(DOPA)PET评估黑质纹状体多巴胺储存能力。
- 每种影像模态均与既往发表的无神经系统疾病或认知障碍的对照者参考数据及有症状帕金森病患者比较,采用校正多重比较的单因素方差分析。
主要发现
- 与对照相比,特发性快速眼动睡眠行为障碍患者结肠11C-多奈哌齐摄取降低(-0·322,95%CI -0·112至-0·531;p=0·0020)。
- 与对照相比,患者123I-MIBG心脏与纵隔比值降低(-0·508,95%CI -0·353至-0·664;p<0·0001)。
- 与对照相比,患者黑素敏感MRI蓝斑与脑桥比值降低(-0·059,95%CI -0·019至-0·099;p=0·0028)。
- 与对照相比,患者壳核18F-DOPA摄取(Ki)降低(-0·0023,95%CI -0·0009至-0·0037;p=0·0013)。
- 特发性快速眼动睡眠行为障碍组与帕金森病组在11C-多奈哌齐(p=0·39)、123I-MIBG(p>0·99)、黑素敏感MRI(p=0·96)和11C-MeNER(p=0·56)方面未检出组间差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Accumulating evidence suggests that α-synuclein aggregates-a defining pathology of Parkinson's disease-display cell-to-cell transmission. α-synuclein aggregation is hypothesised to start in autonomic nerve terminals years before the appearance of motor symptoms, and subsequently spread via autonomic nerves to the spinal cord and brainstem. To assess this hypothesis, we investigated sympathetic, parasympathetic, noradrenergic, and dopaminergic innervation in patients with idiopathic rapid eye movement (REM) sleep behaviour disorder, a prodromal phenotype of Parkinson's disease. METHODS: In this prospective, case-control study, we recruited patients with idiopathic REM sleep behaviour disorder, confirmed by polysomnography, without clinical signs of parkinsonism or dementia, via advertisement and through sleep clinics in Denmark. We used 11C-donepezil PET and CT to assess cholinergic (parasympathetic) gut innervation, 123I-metaiodobenzylguanidine (MIBG) scintigraphy to measure cardiac sympathetic innervation, neuromelanin-sensitive MRI to measure integrity of pigmented neurons of the locus coeruleus, 11C-methylreboxetine (MeNER) PET to assess noradrenergic nerve terminals originating in the locus coeruleus, and 18F-dihydroxyphenylalanine (DOPA) PET to assess nigrostriatal dopamine storage capacity. For each imaging modality, we compared patients with idiopathic REM sleep behaviour disorder with previously published reference data of controls without neurological disorders or cognitive impairment and with symptomatic patients with Parkinson's disease. We assessed imaging data using one-way ANOVA corrected for multiple comparisons. FINDINGS: Between June 3, 2016, and Dec 19, 2017, we recruited 22 consecutive patients with idiopathic REM sleep behaviour disorder to the study. Compared with controls, patients with idiopathic REM sleep behaviour disorder had decreased colonic 11C-donepezil uptake (-0·322, 95% CI -0·112 to -0·531; p=0·0020), 123I-MIBG heart:mediastinum ratio (-0·508, -0·353 to -0·664; p<0·0001), neuromelanin-sensitive MRI locus coeruleus:pons ratio (-0·059, -0·019 to -0·099; p=0·0028), and putaminal 18F-DOPA uptake (Ki; -0·0023, -0·0009 to -0·0037; p=0·0013). No between-group differences were detected between idiopathic REM sleep behaviour disorder and Parkinson's disease groups with respect to 11C-donepezil (p=0·39), 123I-MIBG (p>0·99), neuromelanin-sensitive MRI (p=0·96), and 11C-MeNER (p=0·56). By contrast, 15 (71%) of 21 patients with idiopathic REM sleep behaviour disorder had 18F-DOPA Ki values within normal limits, whereas all patients with Parkinson's disease had significantly decreased 18F-DOPA Ki values when compared with patients with idiopathic REM sleep behaviour disorder (p<0·0001). INTERPRETATION: Patients with idiopathic REM sleep behaviour disorder had fully developed pathology in the peripheral autonomic nervous system and the locus coeruleus, equal to that in diagnosed Parkinson's disease. These patients also showed noradrenergic thalamic denervation, but most had normal putaminal dopaminergic storage capacity. This caudorostral gradient of dysfunction supports the hypothesis that α-synuclein pathology in Parkinson's disease initially targets peripheral autonomic nerves and then spreads rostrally to the brainstem. FUNDING: Lundbeck Foundation, Jascha Foundation, and the Swiss National Foundation.
引用
- Knudsen K, Fedorova TD, Hansen AK, et al. In-vivo staging of pathology in REM sleep behaviour disorder: a multimodality imaging case-control study. Lancet Neurol. 2018. PMID: 29866443. doi:10.1016/S1474-4422(18)30162-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。